Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032073 |
---|---|
Receipt number | R000036588 |
Scientific Title | Safety and efficacy of Glecaprevir / Pibrentasvir combination therapy for chronic hepatitis C - including hemodialysis patients - |
Date of disclosure of the study information | 2018/04/03 |
Last modified on | 2021/06/23 06:21:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/04/03 08:34:00 | ||
2 | Update | 2019/04/07 21:27:16 | Date of IRB Last follow-up date |
|
3 | Update | 2019/09/09 11:57:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Co-sponsor Co-sponsor Organization Organization Address Address Tel Institutions |
|
4 | Update | 2019/09/09 12:01:11 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
5 | Update | 2019/10/12 18:18:45 | Recruitment status |
|
6 | Update | 2019/10/12 18:19:33 | Publication of results Number of participants that the trial has enrolled |
|
7 | Update | 2020/04/29 07:36:28 | Recruitment status |
|
8 | Update | 2021/06/23 06:21:04 | Date analysis concluded |